U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

1.
Figure 2

Figure 2. From: Overall skin tone and skin-lightening-improving effects with oral supplementation of lutein and zeaxanthin isomers: a double-blind, placebo-controlled clinical trial.

Significant increase in elastic recovery after supplementation with L/Zi.
Note: *P<0.05.
Abbreviation: L/Zi, lutein and zeaxanthin isomers.

Vijaya Juturu, et al. Clin Cosmet Investig Dermatol. 2016;9:325-332.
2.
Figure 3

Figure 3. From: Overall skin tone and skin-lightening-improving effects with oral supplementation of lutein and zeaxanthin isomers: a double-blind, placebo-controlled clinical trial.

Potential mechanism of action of L/Zi.
Abbreviations: L/Zi, lutein and zeaxanthin isomers; DHI, dihydroxyindole; P-protein, pink-eyed dilution protein; TRP, tyrosinase related protein.

Vijaya Juturu, et al. Clin Cosmet Investig Dermatol. 2016;9:325-332.
3.
Figure 1

Figure 1. From: Overall skin tone and skin-lightening-improving effects with oral supplementation of lutein and zeaxanthin isomers: a double-blind, placebo-controlled clinical trial.

MED improved after lutein and zeaxanthin isomers (L/Zi) supplementation.
Notes: *Mean significant difference from baseline: placebo: P<0.0139 and **L/Zi (actives): P<0.0001.
Abbreviation: MED, minimal erythemal dose.

Vijaya Juturu, et al. Clin Cosmet Investig Dermatol. 2016;9:325-332.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center